IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Follicular T-NHL Lymphoma
Arbeitsgemeinschaft medikamentoese Tumortherapiemonoclonal_antibodyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
16 Active assets in the Follicular T-NHL Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Pralatrexate Corvus Pharmaceuticals, Inc. | Phase 3 | BB |
FILGRASTIM City of Hope Medical Center | Phase 3 | B |
Soquelitinib Corvus Pharmaceuticals, Inc. | Phase 3 | B |
Pembrolizumab Northwestern University | Phase 2 | B |
Inno-206 City of Hope Medical Center | Phase 2 | B |
View all 18 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →